Supernus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. 

CEO
Jack A. Khattar
CEOJack A. Khattar
Employees
674
Employees674
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2005
Founded2005
Employees
674
Employees674

SUPN Key Statistics

Market cap
2.78B
Market cap2.78B
Price-Earnings ratio
41.95
Price-Earnings ratio41.95
Dividend yield
Dividend yield
Average volume
780.76K
Average volume780.76K
High today
$51.78
High today$51.78
Low today
$49.35
Low today$49.35
Open price
$51.08
Open price$51.08
Volume
2.13M
Volume2.13M
52 Week high
$51.78
52 Week high$51.78
52 Week low
$29.16
52 Week low$29.16

SUPN News

TipRanks 6d
CEO’s Strategic Stock Sale: What It Means for Supernus Pharmaceuticals

New insider activity at Supernus Pharmaceuticals ( (SUPN) ) has taken place on October 3, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Prem...

People also own

Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.